271 related articles for article (PubMed ID: 24168367)
1. Novel approach to the role of NMDA receptors in traumatic brain injury.
Shohami E; Biegon A
CNS Neurol Disord Drug Targets; 2014; 13(4):567-73. PubMed ID: 24168367
[TBL] [Abstract][Full Text] [Related]
2. D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury.
Yaka R; Biegon A; Grigoriadis N; Simeonidou C; Grigoriadis S; Alexandrovich AG; Matzner H; Schumann J; Trembovler V; Tsenter J; Shohami E
FASEB J; 2007 Jul; 21(9):2033-41. PubMed ID: 17351125
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of Brain d-Serine Mediates Recovery of Cognitive Function after Traumatic Brain Injury.
Liraz-Zaltsman S; Slusher B; Atrakchi-Baranes D; Rosenblatt K; Friedman Levi Y; Kesner E; Silva AJ; Biegon A; Shohami E
J Neurotrauma; 2018 Jul; 35(14):1667-1680. PubMed ID: 29648983
[TBL] [Abstract][Full Text] [Related]
4. D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window.
Adeleye A; Shohami E; Nachman D; Alexandrovich A; Trembovler V; Yaka R; Shoshan Y; Dhawan J; Biegon A
Eur J Pharmacol; 2010 Mar; 629(1-3):25-30. PubMed ID: 19958766
[TBL] [Abstract][Full Text] [Related]
5. Focal Cerebral Ischemia and Reperfusion Induce Brain Injury Through α2δ-1-Bound NMDA Receptors.
Luo Y; Ma H; Zhou JJ; Li L; Chen SR; Zhang J; Chen L; Pan HL
Stroke; 2018 Oct; 49(10):2464-2472. PubMed ID: 30355118
[TBL] [Abstract][Full Text] [Related]
6. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.
Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Ye E; Asarnow RF
Schizophr Bull; 2017 Sep; 43(5):1123-1133. PubMed ID: 28338977
[TBL] [Abstract][Full Text] [Related]
7. D-Cycloserine Restores Experience-Dependent Neuroplasticity after Traumatic Brain Injury in the Developing Rat Brain.
Sta Maria NS; Reger ML; Cai Y; Baquing MAT; Buen F; Ponnaluri A; Hovda DA; Harris NG; Giza CC
J Neurotrauma; 2017 Apr; 34(8):1692-1702. PubMed ID: 27931146
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of N-methyl-D-aspartate receptors by exogenous and endogenous ligands improves outcome of brain injury.
Biegon A; Liraz-Zaltsman S; Shohami E
Curr Opin Neurol; 2018 Dec; 31(6):687-692. PubMed ID: 30382950
[TBL] [Abstract][Full Text] [Related]
9. D-Cycloserine enhances the bidirectional range of NMDAR-dependent hippocampal synaptic plasticity.
Vestring S; Dorner A; Scholliers J; Ehrenberger K; Kiss A; Arenz L; Theiss A; Rossner P; Frase S; Du Vinage C; Wendler E; Serchov T; Domschke K; Bischofberger J; Normann C
Transl Psychiatry; 2024 Jan; 14(1):18. PubMed ID: 38195548
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review.
Stutzmann JM; Mary V; Wahl F; Grosjean-Piot O; Uzan A; Pratt J
CNS Drug Rev; 2002; 8(1):1-30. PubMed ID: 12070524
[TBL] [Abstract][Full Text] [Related]
11. Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain.
Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Asarnow RF
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15331-6. PubMed ID: 26621715
[TBL] [Abstract][Full Text] [Related]
12. Memantine improves outcomes after repetitive traumatic brain injury.
Mei Z; Qiu J; Alcon S; Hashim J; Rotenberg A; Sun Y; Meehan WP; Mannix R
Behav Brain Res; 2018 Mar; 340():195-204. PubMed ID: 28412305
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effects of an NMDAR partial agonist in MK-801-induced memory impairment.
Vishnoi S; Raisuddin S; Parvez S
Neuroscience; 2015 Dec; 311():22-33. PubMed ID: 26454025
[TBL] [Abstract][Full Text] [Related]
14. Deficit of NMDA receptor activation in CA1 hippocampal area of aged rats is rescued by D-cycloserine.
Billard JM; Rouaud E
Eur J Neurosci; 2007 Apr; 25(8):2260-8. PubMed ID: 17445224
[TBL] [Abstract][Full Text] [Related]
15. MLC901, a Traditional Chinese Medicine induces neuroprotective and neuroregenerative benefits after traumatic brain injury in rats.
Quintard H; Lorivel T; Gandin C; Lazdunski M; Heurteaux C
Neuroscience; 2014 Sep; 277():72-86. PubMed ID: 24993477
[TBL] [Abstract][Full Text] [Related]
16. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo effects of a novel dimeric inhibitor of PSD-95 on excitotoxicity and functional recovery after experimental traumatic brain injury.
Sommer JB; Bach A; Malá H; Strømgaard K; Mogensen J; Pickering DS
Eur J Neurosci; 2017 Jan; 45(2):238-248. PubMed ID: 27859797
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury.
Merchant RE; Bullock MR; Carmack CA; Shah AK; Wilner KD; Ko G; Williams SA
Ann N Y Acad Sci; 1999; 890():42-50. PubMed ID: 10668412
[TBL] [Abstract][Full Text] [Related]
19. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
[TBL] [Abstract][Full Text] [Related]
20. Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder.
Heresco-Levy U; Javitt DC; Gelfin Y; Gorelik E; Bar M; Blanaru M; Kremer I
J Affect Disord; 2006 Jul; 93(1-3):239-43. PubMed ID: 16677714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
